Sangamo Biosciences (NASDAQ: SGMO) has recently received a number of price target changes and ratings updates: 9/11/2015 – Sangamo Biosciences had its “buy” rating reaffirmed by analysts at Piper Jaffray. They now have a $17.00 price target on the stock. 9/7/2015 – Sangamo Biosciences was downgraded by analysts at Zacks from a “hold” rating to […]
